Works by Leng, Yun

Results: 39
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.

    Published in:
    Thrombosis Journal, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12959-023-00534-y
    By:
    • Li, Xiaozhe;
    • Sun, Xiuli;
    • Fang, Baijun;
    • Leng, Yun;
    • Sun, Fangfang;
    • Wang, Yaomei;
    • Wang, Qing;
    • Jin, Jie;
    • Yang, Min;
    • Xu, Bing;
    • Fang, Zhihong;
    • Chen, Lijuan;
    • Chen, Zhi;
    • Yang, Qimei;
    • Zhang, Kejie;
    • Ye, Yinhai;
    • Geng, Hui;
    • Sun, Zhiqiang;
    • Hao, Dan;
    • Huang, Hongming
    Publication type:
    Article
    36
    37
    38
    39

    Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11489-8
    By:
    • Xia, Zhongjun;
    • Leng, Yun;
    • Fang, Baijun;
    • Liang, Yang;
    • Li, Wei;
    • Fu, Chengcheng;
    • Yang, Linhua;
    • Ke, Xiaoyan;
    • Jiang, Hua;
    • Weng, Jianyu;
    • Liu, Li;
    • Zhao, Yaozhong;
    • Zhang, Xuejun;
    • Huang, Zhongxia;
    • Liu, Aichun;
    • Shi, Qingzhi;
    • Gao, Yuhuan;
    • Chen, Xiequn;
    • Pan, Ling;
    • Cai, Zhen
    Publication type:
    Article